Emerging infectious diseases: public health issues for the 21st century.

Infectious diseases are the third leading cause of death in the United States and the leading cause worldwide. As the new millennium approaches, the public health community must replenish capacity depleted during years of inadequate funding while simultaneously incorporating new technologies and planning for the longer term. Among the challenges facing the public health community is the need for coordinated, global, multisectoral approaches to preventing and controlling complex infectious disease problems.

[1]  S. Ostroff,et al.  Emerging infectious diseases and travel medicine. , 1998, Infectious disease clinics of North America.

[2]  L. Slutsker,et al.  EMERGEncy ID NET: an emergency department-based emerging infections sentinel network. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[3]  S M Teutsch,et al.  Trends in infectious diseases mortality in the United States. , 1996, JAMA.

[4]  D. Greenberg,et al.  Reduction of nasopharyngeal carriage of pneumococci during the second year of life by a heptavalent conjugate pneumococcal vaccine. , 1996, The Journal of infectious diseases.

[5]  David Classen,et al.  Implementing Antibiotic Practice Guidelines through Computer-Assisted Decision Support: Clinical and Financial Outcomes , 1996, Annals of Internal Medicine.

[6]  J. Mcnicholl,et al.  Host genes and infectious diseases. , 1998, Emerging infectious diseases.

[7]  L. Reichman,et al.  How to ensure the continued resurgence of tuberculosis , 1996, The Lancet.

[8]  J M Hughes,et al.  Infectious disease surveillance: a crumbling foundation. , 1994, Science.

[9]  H. Bauchner,et al.  Parents, physicians, and antibiotic use. , 1999, Pediatrics.

[10]  A J Moskowitz,et al.  Cost-effectiveness of vaccination against pneumococcal bacteremia among elderly people. , 1997, JAMA.

[11]  A. Moffat.  Exploring transgenic plants as a new vaccine source , 1995, Science.

[12]  A. Troesch,et al.  Mycobacterium Species Identification and Rifampin Resistance Testing with High-Density DNA Probe Arrays , 1999, Journal of Clinical Microbiology.

[13]  R. Webster,et al.  Influenza: an emerging disease. , 1998, Emerging infectious diseases.

[14]  R. Kahn,et al.  Post-transfusion Hepatitis: Current Perspectives , 1980 .

[15]  R. Rasooly,et al.  Autoinducer of virulence as a target for vaccine and therapy against Staphylococcus aureus. , 1998, Science.

[16]  D A Henderson,et al.  The looming threat of bioterrorism. , 1999, Science.

[17]  D. Relman.  The search for unrecognized pathogens. , 1999, Science.

[18]  H. Robinson,et al.  Nucleic acid vaccines: an overview. , 1997, Vaccine.

[19]  N. Cox,et al.  Characterization of an avian influenza A (H5N1) virus isolated from a child with a fatal respiratory illness. , 1998, Science.

[20]  D. Lawrence,et al.  Human immunodeficiency virus infection due to clotting factor concentrates: results of the Seroconversion Surveillance Project , 1992, Transfusion.

[21]  B. Cornell,et al.  A biosensor that uses ion-channel switches , 1997, Nature.